Clinic
Agh Mesa LLC
Agh Mesa LLC was paid $3.34M by Medicaid between Dec 2019 and Dec 2024, across 65 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
33Billing provider infoAGH MESA LLC
TEMPE, AZ 85282
TEMPE, AZ 85282
33aNPI1528525227assigned 02/28/2019
33bProvider typeEmergency Care Clinic/Center
28Total paid$3.34M
24GClaims56,942
24DCodes billed65
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Arizona
Rank by total paid#10 of 28
Median peer was paid$2.32M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANSON, JANE controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 13 | $4K | |
| 2020 | 40 | $8K | |
| 2021 | 167 | $31K | |
| 2022 | 9,377 | $548K | |
| 2023 | 23,840 | $1.38M | |
| 2024incomplete | 23,505 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 10,726 | 10,127 | $1.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 4,502 | 4,291 | $833K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.6% | 642 | 632 | $319K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.0% | 896 | 864 | $268K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.9% | 2,446 | 2,341 | $196K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.4% | 395 | 385 | $148K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 362 | 345 | $63K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,556 | 1,483 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,327 | 1,249 | $938.99 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 70 | 66 | $433.55 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 412 | 398 | $297.39 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 325 | 318 | $172.55 |
53 more codes
| 87631 | <1% | 568 | $135.67 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 965 | $113.04 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,966 | $113.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 888 | $93.14 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,132 | $88.35 |
| 80053 | Comprehensive metabolic panel | <1% | 3,054 | $81.92 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,041 | $64.12 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 250 | $51.31 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,124 | $38.11 |
| 73630 | <1% | 147 | $34.74 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,861 | $27.86 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 585 | $27.47 |
| 81003 | <1% | 2,046 | $23.26 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 313 | $21.43 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,140 | $20.22 |
| 84484 | <1% | 607 | $18.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,251 | $18.39 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 184 | $18.05 |
| 81025 | <1% | 1,539 | $14.74 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 315 | $13.97 |
| J3490 | Unclassified drugs | <1% | 1,000 | $6.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 125 | $5.26 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,175 | $4.75 |
| 82803 | 0% | 158 | $0.00 | |
| 80051 | 0% | 151 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,379 | $0.00 |
| 85379 | 0% | 138 | $0.00 | |
| 83605 | 0% | 161 | $0.00 | |
| 87428 | 0% | 74 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 382 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 104 | $0.00 |
| 87480 | 0% | 14 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 421 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 113 | $0.00 |
| 82550 | 0% | 151 | $0.00 | |
| 82553 | 0% | 232 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 92 | $0.00 |
| 93971 | 0% | 13 | $0.00 | |
| 82962 | 0% | 12 | $0.00 | |
| 87510 | 0% | 14 | $0.00 | |
| 73130 | 0% | 103 | $0.00 | |
| 84702 | 0% | 262 | $0.00 | |
| 82947 | 0% | 77 | $0.00 | |
| 87660 | 0% | 14 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 242 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 258 | $0.00 |
| 82565 | 0% | 78 | $0.00 | |
| 73610 | 0% | 137 | $0.00 | |
| 90715 | 0% | 112 | $0.00 | |
| 84520 | 0% | 78 | $0.00 | |
| 93976 | 0% | 12 | $0.00 | |
| 73030 | 0% | 13 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANSON, JANE (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Agh Laveen LLC | Laveen, AZ | $109.33M |
| Agh Mesa LLC | Mesa, AZ | $28.01M |
| Agh Laveen LLC | Glendale, AZ | $14.88M |
| Agh Mesa LLC | Mesa, AZ | $4.69M |
| Agh Laveen LLC | Goodyear, AZ | $4.04M |
| Agh Laveen LLC | Surprise, AZ | $3.48M |
| Agh Laveen LLC | Glendale, AZ | $3.40M |
| Agh Mesa LLC | Chandler, AZ | $2.76M |
| Agh Mesa LLC | Mesa, AZ | $2.66M |
| Agh Mesa LLC | San Tan Valley, AZ | $2.32M |
| Agh Mesa LLC | Phoenix, AZ | $1.74M |
| Agh Mesa LLC | Chandler, AZ | $1.12M |
| Agh Mesa LLC | Gilbert, AZ | $978K |
| Agh Laveen LLC | Mesa, AZ | $293K |
| Agh Laveen LLC | Chandler, AZ | $259K |
| Agh Laveen LLC | Phoenix, AZ | $184K |
| Agh Laveen LLC | Mesa, AZ | $167K |
| Agh Laveen LLC | Gilbert, AZ | $160K |
| Agh Laveen LLC | Chandler, AZ | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.